PharMEDium Services participates in APSF Summit held in Phoenix, AZ

NewsGuard 100/100 Score

PharMEDium Services, LLC, announced their participation in the Anesthesia Patient Safety Foundation (APSF) Summit held January 26th in Phoenix, AZ.

PharMEDium's commitment to patient safety aligned with the APSF goals of improving medication safety by offering a complete line of pre-filled, pre-labeled Anesthesia syringe medications intended for use in the Operating Room. "Pre-filled, pre-labeled syringes can support the hospital in being compliant with regulatory requirements for proper labeling. In addition, this service can support standardization of medications in this critical environment. Standardized barcodes are included on all syringe labels further enhancing the ability to integrate with new technologies designed to enhance patient safety " said David Jonas, PharMEDium's Chairman and Chief Executive Officer. "APSF's vision and leadership in bringing together this diverse group of opinion leaders shows an unwavering commitment to advancing patient safety in the Operating Room. A consensus involving the anesthesia, pharmacy, nursing and regulatory community is exceptional in the movement to improve patient safety in our healthcare system. This summit could not have been possible without the collaborative approach by APSF," he added.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.